Cargando…

Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients

OBJECTIVE: To examine the impact of sustained virologic response (SVR) and illicit (injection and noninjection) drug use on kidney function among hepatitis C virus (HCV) and HIV co-infected individuals. DESIGN: Longitudinal observational cohort study of HCV-HIV co-infected patients. METHODS: Data fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Carmine, Saeed, Sahar, Cox, Joseph, Vachon, Marie-Louise, Martel-laferrière, Valérie, Walmsley, Sharon L., Cooper, Curtis, Gill, M. John, Hull, Mark, Moodie, Erica E.M., Klein, Marina B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5895129/ https://www.ncbi.nlm.nih.gov/pubmed/29369156 http://dx.doi.org/10.1097/QAD.0000000000001750

Ejemplares similares

Frequent injection cocaine use increases the risk of renal impairment among hepatitis C and HIV coinfected patients
por: Rossi, Carmine, et al.
Publicado: (2016)

Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
por: Marathe, Gayatri, et al.
Publicado: (2022)

Previous incarceration impacts access to hepatitis C virus (HCV) treatment among HIV‐HCV co‐infected patients in Canada
por: Kronfli, Nadine, et al.
Publicado: (2018)

Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus
por: Saeed, Sahar, et al.
Publicado: (2020)

Trends in cause-specific mortality in HIV–hepatitis C coinfection following hepatitis C treatment scale-up
por: Kronfli, Nadine, et al.
Publicado: (2019)

Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV
por: Young, Jim, et al.
Publicado: (2017)

Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons
por: Brunet, Laurence, et al.
Publicado: (2016)

Disparities in direct acting antivirals uptake in HIV‐hepatitis C co‐infected populations in Canada
por: Saeed, Sahar, et al.
Publicado: (2017)

Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning
por: Marathe, Gayatri, et al.
Publicado: (2022)

Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care
por: Rossi, Carmine, et al.
Publicado: (2019)

How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?
por: Saeed, Sahar, et al.
Publicado: (2016)

Estimating an individual-level deprivation index for HIV/HCV coinfected persons in Canada
por: Palayew, Adam, et al.
Publicado: (2021)

Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy
por: Rossi, Carmine, et al.
Publicado: (2017)

Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study
por: Martel-Laferrière, Valérie, et al.
Publicado: (2017)

Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis
por: Costiniuk, Cecilia T., et al.
Publicado: (2016)

Marijuana Smoking Does Not Accelerate Progression of Liver Disease in HIV–Hepatitis C Coinfection: A Longitudinal Cohort Analysis
por: Brunet, Laurence, et al.
Publicado: (2013)

Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection – The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index
por: Rollet-Kurhajec, Kathleen C., et al.
Publicado: (2015)

A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection
por: Moqueet, Nasheed, et al.
Publicado: (2017)

Favourable IFNL3 Genotypes Are Associated with Spontaneous Clearance and Are Differentially Distributed in Aboriginals in Canadian HIV-Hepatitis C Co-Infected Individuals
por: Moqueet, Nasheed, et al.
Publicado: (2015)

Role of fatty liver in the epidemic of advanced chronic liver disease among people with HIV: protocol for the Canadian LIVEHIV multicentre prospective cohort
por: Cinque, Felice, et al.
Publicado: (2023)

Patients Followed in an Addiction Medicine Clinic Are Less Likely to Be Eligible to Hepatitis C Drug Studies Regardless of Drug Use
por: Doré, Gabrielle, et al.
Publicado: (2017)

MELD score and antibiotics use are predictors of length of stay in patients hospitalized with hepatic encephalopathy
por: Martel-Laferrière, Valérie, et al.
Publicado: (2014)

Food Insecurity in HIV-Hepatitis C Virus Co-infected Individuals in Canada: The Importance of Co-morbidities
por: Cox, Joseph, et al.
Publicado: (2016)

A secondary syphilis rash with scaly target lesions
por: Marchand-Senécal, Xavier, et al.
Publicado: (2018)

Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV–Hepatitis C Virus Coinfection
por: Moqueet, Nasheed, et al.
Publicado: (2016)

Differences in Antiretroviral Adherence Behaviors, Treatment Success, and Eligibility for Long-Acting Injectable Treatment between Patients Who Acquired HIV in Childhood vs. Those Who Acquired It in Adolescence/Early Adulthood
por: Marcellin, Anthony, et al.
Publicado: (2022)

Decline of Humoral Responses against SARS-CoV-2 Spike in Convalescent Individuals
por: Beaudoin-Bussières, Guillaume, et al.
Publicado: (2020)

Virological Outcomes After Switching to Abacavir/Lamivudine/Dolutegravir Combined with Adherence Support in People Living with HIV with Poor Adherence: A Phase IV, Multicentre Randomized Prospective Open Label Study (TriiADD-CTN 286)
por: Klein, Marina B, et al.
Publicado: (2022)

General regression methods for respondent-driven sampling data
por: Yauck, Mamadou, et al.
Publicado: (2021)

The epidemiological impact of the Canadian COVID Alert app
por: Sun, Shuo, et al.
Publicado: (2022)

Estimating individualized treatment rules in longitudinal studies with covariate-driven observation times
por: Coulombe, Janie, et al.
Publicado: (2023)

Immunogenicity Is Not Improved by Increased Antigen Dose or Booster Dosing of Seasonal Influenza Vaccine in a Randomized Trial of HIV Infected Adults
por: Cooper, Curtis, et al.
Publicado: (2011)

Codeveloping a Virtual Patient Simulation to Foster Nurses’ Relational Skills Consistent With Motivational Interviewing: A Situation of Antiretroviral Therapy Nonadherence
por: Rouleau, Geneviève, et al.
Publicado: (2020)

Great and Desperate Cures: The Rise and Decline of Psychosurgery & Other Radical Treatments for Mental Illness
por: Rice, Henry
Publicado: (1986)

Vibrio cholerae in Traveler from Haiti to Canada
por: Gilmour, Matthew W., et al.
Publicado: (2011)

426 Association between pre-transplant Staphylococcus aureus colonisation and post-transplant S. aureus infection among cystic fibrosis lung transplant recipients
por: St-Pierre, Jessica, et al.
Publicado: (2014)

Formulating causal questions and principled statistical answers
por: Goetghebeur, Els, et al.
Publicado: (2020)

Impact of an Accelerated Pretreatment Evaluation on Linkage-to-Care for Hepatitis C-infected Persons Who Inject Drugs
por: Martel-Laferrière, Valérie, et al.
Publicado: (2022)

CIHR Canadian HIV Trials Network Co-Infection and Concurrent Diseases Core: Updated Canadian guidelines for the treatment of hepatitis C infection in HIV-hepatitis C coinfected adults
por: Hull, Mark, et al.
Publicado: (2014)

Cure for Snake-Bite by Actual Cautery
por: Cox, H. W. V.
Publicado: (1914)

Cannot write session to /tmp/vufind_sessions/sess_uvurj9m2d72qot4jso81e2jdsa